Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Behavioral Medicine
Published in: Annals of Behavioral Medicine 3/2015

01-06-2015 | Original Article

The ABCs of Trait Anger, Psychological Distress, and Disease Severity in HIV

Authors: Roger C. McIntosh, Ph.D., Barry E. Hurwitz, Ph.D., Michael Antoni, Ph.D., Alex Gonzalez, B.A., Julia Seay, M.S., Neil Schneiderman, Ph.D.

Published in: Annals of Behavioral Medicine | Issue 3/2015

Login to get access

Abstract

Background

Trait anger consists of affective, behavioral, and cognitive (ABC) dimensions and may increase vulnerability for interpersonal conflict, diminished social support, and greater psychological distress. The concurrent influence of anger and psychosocial dysfunction on Human Immunodeficiency Virus (HIV) disease severity is unknown.

Purpose

The purpose of this study was to examine plausible psychosocial avenues (e.g., coping, social support, psychological distress), whereby trait anger may indirectly influence HIV disease status.

Methods

Three hundred seventy-seven HIV seropositive adults, aged 18–55 years (58 % AIDS-defined), completed a battery of psychosocial surveys and provided a fasting blood sample for HIV-1 viral load and T lymphocyte count assay.

Results

A second-order factor model confirmed higher levels of the multidimensional anger trait, which was directly associated with elevated psychological distress and avoidant coping (p < .001) and indirectly associated with greater HIV disease severity (p < .01) (comparative fit index (CFI) = 0.90, root-mean-square error of approximation (RMSEA) = 0.06, standardized root-mean-square residual (SRMR) = 0.06).

Conclusion

The model supports a role for the ABC components of anger, which may negatively influence immune function through various psychosocial mechanisms; however, longitudinal study is needed to elucidate these effects.
Literature
1.
Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010; 376: 49-62.PubMed
2.
Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998; 338: 853-860.PubMed
3.
May MT, Sterne J, Costagliola D, et al. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: A collaborative analysis. Lancet. 2006; 368: 451-458.PubMed
4.
Lodi S, Phillips A, Touloumi G, et al. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds < 200,< 350, and < 500 cells/mm3: Assessment of need following changes in treatment guidelines. Clin Infect Dis. 2011; 53: 817-825.PubMed
5.
Penedo FJ, Gonzalez JS, Davis C, et al. Coping and psychological distress among symptomatic HIV+ men who have sex with men. Ann Behav Med. 2003; 25: 203-213.PubMed
6.
Segerstrom SC, Miller GE. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol Bull. 2004; 130: 601.PubMedCentralPubMed
7.
Glaser R, Rabin B, Chesney M, Cohen S, Natelson B. Stress-induced immunomodulation. JAMA: J Am Med Assoc. 1999; 281: 2268-2270.
8.
Biondi M, Zannino L-G. Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: A review. Psychother Psychosom. 1997; 66: 3-26.PubMed
9.
Yang E, Glaser R. Stress-induced immunomodulation: Impact on immune defenses against infectious disease. Biomed Pharmacother. 2000; 54: 245-250.PubMed
10.
Motivala SJ, Hurwitz BE, Llabre MM, et al. Psychological distress is associated with decreased memory helper T-cell and B-cell counts in pre-AIDS HIV seropositive men and women but only in those with low viral load. Psychosom Med. 2003; 65: 627-635.PubMed
11.
Greeson JM, Hurwitz BE, Llabre MM, et al. Psychological distress, killer lymphocytes and disease severity in HIV/AIDS. Brain Behav Immun. 2008; 22: 901-911.PubMed
12.
Giorgi JV, Lyles RH, Matud JL, et al. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. JAIDS J Acquir Immune Defic Syndr. 2002; 29: 346-355.
13.
Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol. 2002; 169: 3400-3406.PubMed
14.
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annu Rev Psychol. 2002; 53: 83-107.PubMed
15.
Martin R, Watson D, Wan CK. A three‐factor model of trait anger: Dimensions of affect, behavior, and cognition. J Pers. 2000; 68: 869-897.PubMed
16.
Smith TW. Concepts and methods in the study of anger, hostility, and health. Anger Hostility Heart. 1994; 23–42.
17.
Buss AH. The psychology of aggression. Wiley: New York, US; 1961.
18.
Viney LL, Henry R, Walker BM, Crooks L. The emotional reactions of HIV antibody positive men. Br J Med Psychol. 1989; 62: 153-161.PubMed
19.
Earnshaw VA, Kalichman SC: Stigma experienced by people living with HIV/AIDS. Stigma, Discrimination and Living with HIV/AIDS: Springer, 2013, 23-38
20.
Brook DW, Brook JS, Richter L, et al.: Coping strategies of HIV-positive and HIV-negative female injection drug users: A longitudinal study. AIDS education and prevention. 1999.
21.
Barefoot JC, Peterson BL, Dahlstrom WG, et al. Hostility patterns and health implications: Correlates of Cook-Medley Hostility Scale scores in a national survey. Health Psychol. 1991; 10: 18.PubMed
22.
Bravo P, Edwards A, Rollnick S, Elwyn G. Tough decisions faced by people living with HIV: A literature review of psychosocial problems. Aids Rev. 2010; 12: 76-88.PubMed
23.
Gallo LC, Smith TW. Patterns of hostility and social support: Conceptualizing psychosocial risk factors as characteristics of the person and the environment. J Res Pers. 1999; 33: 281-310.
24.
Hardy JD, Smith TW. Cynical hostility and vulnerability to disease: Social support, life stress, and physiological response to conflict. Health Psychol. 1988; 7: 447.PubMed
25.
Hart KE. Perceived availability of different types of social support among cynically hostile women. J Clin Psychol. 1996; 52: 383-387.PubMed
26.
Watkins PL, Ward CH, Southard DR, Fisher EB. The Type a belief system: Relationships to hostility, social support, and life stress. Behav Med. 1992; 18: 27-32.PubMed
27.
Benotsch EG, Christensen AJ, McKelvey L. Hostility, social support, and ambulatory cardiovascular activity. J Behav Med. 1997; 20: 163-176.PubMed
28.
Guyll M, Contrada RJ. Trait hostility and ambulatory cardiovascular activity: Responses to social interaction. Health Psychol. 1998; 17: 30.PubMed
29.
Uchino BN. Social support and health: A review of physiological processes potentially underlying links to disease outcomes. J Behav Med. 2006; 29: 377-387.PubMed
30.
Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans. JAIDS J Acquir Immune Defic Syndr. 2005; 38: 213-218.
31.
Corbie‐Smith G, Thomas SB, Williams MV, Moody‐Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999; 14: 537-546.PubMedCentralPubMed
32.
Klonoff EA, Landrine H. Do blacks believe that HIV/AIDS is a government conspiracy against them. Prev Med. 1999; 28: 451-457.PubMed
33.
Sengupta S, Strauss RP, DeVellis R, et al. Factors affecting African-American participation in AIDS research. JAIDS J Acquir Immune Defic Syndr. 2000; 24: 275-284.
34.
Ashton E, Vosvick M, Chesney M, et al. Social support and maladaptive coping as predictors of the change in physical health symptoms among persons living with HIV/AIDS. AIDS Patient Care STDs. 2005; 19: 587-598.PubMed
35.
Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004; 23: 413.PubMed
36.
Ironson G, Hayward HS. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom Med. 2008; 70: 546-554.PubMedCentralPubMed
37.
Brownley KA, Light KC, Anderson NB. Social support and hostility interact to influence clinic, work, and home blood pressure in Black and White men and women. Psychophysiology. 1996; 33: 434-445.PubMed
38.
Hart KE, Hope CW. Cynical hostility and the psychosocial vulnerability model of disease risk: Confounding effects of neuroticism (negative affectivity) bias. Personal Individ Differ. 2004; 36: 1571-1582.
39.
Felsten G. Hostility, stress and symptoms of depression. Personal Individ Differ. 1996; 21: 461-467.
40.
Heponiemi T, Elovainio M, Kivimäki M, et al. The longitudinal effects of social support and hostility on depressive tendencies. Soc Sci Med. 2006; 63: 1374-1382.PubMed
41.
Nabi H, Singh-Manoux A, Ferrie JE, et al. Hostility and depressive mood: Results from the Whitehall II prospective cohort study. Psychol Med. 2010; 40: 405.PubMed
42.
Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull. 2005; 131: 260.PubMed
43.
Vandervoort D. Depression, anxiety, hostility, and physical health. Curr Psychol. 1995; 14: 69-82.
44.
Blaney NT, Morgan RO, Feaster D, et al. Cynical hostility: A risk factor in HIV‐1 infection? 1. J Appl Soc Psychol. 1991; 21: 668-695.
45.
Weaver KE, Llabre MM, Durán RE, et al. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol. 2005; 24: 385.PubMed
46.
Hartzell JD, Janke IE, Weintrob AC. Impact of depression on HIV outcomes in the HAART era. J Antimicrob Chemother. 2008; 62: 246-255.PubMed
47.
Leserman J, Petitto JM, Golden RN, et al. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatr. 2000; 157: 1221-1228.PubMed
48.
Maan Diong S, Bishop GD, Enkelmann HC, et al. Anger, stress, coping, social support and health: Modelling the relationships. Psychol Health. 2005; 20: 467-495.
49.
Vandervoort DJ. Hostility and health: Mediating effects of belief systems and coping styles. Curr Psychol. 2006; 25: 50-66.
50.
Chida Y, Vedhara K. Adverse psychosocial factors predict poorer prognosis in HIV disease: A meta-analytic review of prospective investigations. Brain Behav Immun. 2009; 23: 434-445.PubMed
51.
McIntosh RC, Rosselli M. Stress and coping in women living with HIV: A meta-analytic review. AIDS Behav. 2012; 16: 2144-2159.PubMed
52.
Moskowitz JT, Hult JR, Bussolari C, Acree M. What works in coping with HIV? A meta-analysis with implications for coping with serious illness. Psychol Bull. 2009; 135: 121.PubMed
53.
Castro KG, Ward JW, Slutsker L, et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clin Infect Dis. 1993; 17: 802-810.
54.
Chesney MA, Ickovics J, Chambers D, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000; 12: 255-266.PubMed
55.
Spielberger CD, Johnson EH, Russell SF, et al. The experience and expression of anger: Construction and validation of an anger expression scale. Anger Hostility Cardiovas Behav Disord. 1985; 5–30.
56.
Cook WW, Medley DM. Proposed hostility and pharisaic-virtue scales for the MMPI. J Appl Psychol. 1954; 38: 414.
57.
Costa PT, Zonderman AB, McCrae RR, Williams RB. Cynicism and paranoid alienation in the Cook and Medley HO Scale. Psychosom Med. 1986; 48: 283-285.PubMed
58.
Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol. 1989; 56: 267.PubMed
59.
Cutrona CE, Russell DW. The provisions of social relationships and adaptation to stress. Adv Pers Relatsh. 1987; 1: 37-67.
60.
Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med. 1979; 41: 209-218.PubMed
61.
Beck AT, Ward C, Mendelson M. Beck depression inventory (BDI). Arch Gen Psychiatry. 1961; 4: 561-571.PubMed
62.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983; 385–396.
63.
Enders CK, Bandalos DL. The relative performance of full information maximum likelihood estimation for missing data in structural equation models. Struct Equ Model. 2001; 8: 430-457.
64.
Kline RB. Principles and practice of structural equation modeling: Guilford press. 2011.
65.
Muthén L, Muthén B: Mplus. Statistical analysis with latent variables. Version. 2007, 3.
66.
Byrne BM. Structural equation modeling with Mplus: Basic concepts, applications, and programming. New York: Routledge Academic; 2011.
67.
Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990; 107: 238.PubMed
68.
Jöreskog KG, Sörbom D. Lisrel 8: Structured equation modeling with the Simplis command language: Scientific Software International. 1993.
69.
Steiger JH. Structural model evaluation and modification: An interval estimation approach. Multivar Behav Res. 1990; 25: 173-180.
70.
Lt H. Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Model: Multidiscip J. 1999; 6: 1-55.
71.
Hooper D, Coughlan J, Mullen M. Structural equation modelling: Guidelines for determining model fit. Articles. 2008; 2.
72.
Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res Online. 2003; 8: 23-74.
73.
Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: An exploration and elaboration of a stigma trajectory. Soc Sci Med. 1995; 41: 303-315.PubMed
74.
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008; 70: 539-545.PubMed
75.
Barefoot JC, Dodge KA, Peterson BL, Dahlstrom WG, Williams RB. The Cook-Medley hostility scale: Item content and ability to predict survival. Psychosom Med. 1989; 51: 46-57.PubMed
76.
Giancola PR, Saucier DA. Gussler‐Burkhardt NL: The Effects of Affective, Behavioral, and Cognitive Components of Trait Anger on the Alcohol‐Aggression Relation. Alcohol Clin Exp Res. 2003; 27: 1944-1954.PubMed
77.
Evans DL, Leserman J, Perkins DO, et al. Severe life stress as a predictor of early disease progression in HIV infection. Am J Psychiatr. 1997; 154: 630-634.PubMed
78.
Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008; 5: 163-171.PubMed
79.
Del Guerra F, Fonseca J, Figueiredo V, Ziff E, Konkiewitz EC. Human immunodeficiency virus-associated depression: Contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J Neurovirol. 2013; 1–14.
80.
Schuster R, Bornovalova M, Hunt E. The Influence of depression on the progression of HIV direct and indirect effects. Behav Modif. 2012; 36: 123-145.PubMed
81.
Beck AT: Prisoners of hate: HarperCollins, 2010
82.
Deffenbacher JL, Oetting ER, Lynch RS, Morris CD. The expression of anger and its consequences. Behav Res Ther. 1996; 34: 575-590.PubMed
83.
Martin RC, Dahlen ER. Cognitive emotion regulation in the prediction of depression, anxiety, stress, and anger. Personal Individ Differ. 2005; 39: 1249-1260.
84.
Vandervoort DJ. Belief systems and coping styles as mediating variables in the relationship between hostility and illness. Curr Psychol. 1992; 11: 226-235.
85.
Fitzgerald GJ. Hostility now, depression later? Longitudinal associations among emotional risk factors for coronary artery disease. Ann Behav Med. 2010; 39: 258-266.PubMedCentralPubMed
86.
Gonzalez JS, Penedo FJ, Llabre MM, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 2007; 34: 46-55.PubMed
87.
Llabre MM, Weaver KE, Durán RE, et al. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Car STDs. 2006; 20: 701-711.
88.
Penedo FJ, Gonzalez JS, Dahn JR, et al. Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. J Psychosom Res. 2003; 54: 271-278.PubMed
89.
Gore-Felton C, Koopman C, Spiegel D, et al. Effects of quality of life and coping on depression among adults living with HIV/AIDS. J Health Psychol. 2006; 11: 711-729.PubMed
90.
McIntosh RC, Seay JS, Antoni MH, Schneiderman N: Cognitive vulnerability for depression in HIV. Journal of affective disorders. 2013.
91.
van der Veek SM, Kraaij V, Van Koppen W, Garnefski N, Joekes K. Goal disturbance, cognitive coping and psychological distress in HIV-infected persons. J Health Psychol. 2007; 12: 225-230.PubMed
92.
Antoni M, Ironson G, Schneiderman N. Stress management for persons with HIV infection. New York: Oxford University Press; 2007.
93.
Lutgendorf SK, Antoni MH, Ironson G, et al. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosom Med. 1998; 60: 204-214.PubMed
94.
Cruess S, Antoni M, Cruess D, et al. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med. 2000; 62: 828-837.PubMed
95.
Antoni M, Cruess D, Wagner S, et al. Cognitive behavioral stress management effects on anxiety, 24-hour urinary catecholamine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol. 2000; 68: 31-45.PubMed
96.
Antoni MH, Cruess S, Cruess DG, et al. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med. 2000; 22: 29-37.PubMed
97.
Antoni MH, Carrico AW, Durán RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006; 68: 143-151.PubMed
98.
Antoni MH, Pereira DB, Marion I, et al. Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women. J Psychosom Res. 2008; 65: 389-401.PubMedCentralPubMed
99.
Antoni MH, Cruess DG, Klimas N, et al. Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected men. J Psychosom Res. 2005; 58: 3-13.PubMed
100.
Antoni MH, Cruess DG, Klimas N, et al. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: Effects on transitional naïve T cells (CD4+ CD45RA+ CD29+). Am J Psychiatr. 2002; 159: 143-145.PubMed
101.
Schieman S. Age and anger. J Health Soc Behav. 1999; 273–289.
102.
Phillips L, Henry J, Hosie J, Milne A. Age, anger regulation and well-being. Aging Ment Health. 2006; 10: 250-256.PubMed
103.
Singh N, Squier C, Sivek C, Wagener MM, Victor LY. Psychological stress and depression in older patients with intravenous drug use and human immunodeficiency virus infection: Implications for intervention. Int J STD AIDS. 1997; 8: 251-255.PubMed
104.
LeBlanc AJ. Aging with HIV/AIDS. Handbook of Sociology of Aging: Springer; 2011: 495-512.
105.
Catz SL, Gore-Felton C, McClure JB. Psychological distress among minority and low-income women living with HIV. Behav Med. 2002; 28: 53-60.PubMed
106.
Watkins DC. Depression Over the Adult Life Course for African American Men Toward a Framework for Research and Practice. Am J Men’s Health. 2012; 6: 194-210.
107.
Mabry JB, Kiecolt KJ. Anger in black and white: Race, alienation, and anger. J Health Soc Behav. 2005; 46: 85-101.PubMed
108.
Scherwitz L, Perkins L, Chesney M, Hughes G. Cook-Medley Hostility scale and subsets: Relationship to demographic and psychosocial characteristics in young adults in the CARDIA study. Psychosom Med. 1991; 53: 36-49.PubMed
109.
110.
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000; 133: 21-30.PubMed
111.
Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. J Acquir Immune Defic Syndr. 1999; 2011: 58.
112.
Springer SA, Dushaj A, Azar MM. The impact of DSM-IV Mental Disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: A systematic review. AIDS Behav. 2012; 16: 2119-2143.PubMedCentralPubMed
113.
Burgoyne R, Renwick R. Social support and quality of life over time among adults living with HIV in the HAART era. Soc Sci Med. 2004; 58: 1353-1366.PubMed
114.
Jia H, Uphold CR, Wu S, Chen GJ, Duncan PW. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Patient Care STDs. 2005; 19: 395-405.PubMed
115.
Pakenham KI, Dadds MR, Terry DJ. Relationship between adjustment to HIV and both social support and coping. J Consult Clin Psychol. 1994; 62: 1194.PubMed
116.
Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA: J Am Med Assoc. 2001; 286: 2568-2577.
117.
Paredes R, Mocroft A, Kirk O, et al. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: Results from the EuroSIDA study. Arch Intern Med. 2000; 160: 1123.PubMed
118.
Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001; 135: 17-26.PubMed
119.
Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States—an analysis of cost-effectiveness. N Engl J Med. 2005; 352: 586-595.PubMed
120.
Kass NE, Munoz A, Chen B, et al. Changes in employment, insurance, and income in relation to HIV status and disease progression. JAIDS J Acquir Immune Defic Syndr. 1994; 7: 86-91.
121.
Rueda S, Raboud J, Mustard C, et al. Employment status is associated with both physical and mental health quality of life in people living with HIV. AIDS Care. 2011; 23: 435-443.PubMed
122.
White L, Cant B. Social networks, social support, health and HIV‐positive gay men. Health Soc Care Commun. 2003; 11: 329-334.
123.
Carrico AW, Antoni MH, Durán RE, et al. Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-positive gay men treated with HAART. Ann Behav Med. 2006; 31: 155-164.PubMed
124.
Gallo LC, Matthews KA. Understanding the association between socioeconomic status and physical health: Do negative emotions play a role. Psychol Bull. 2003; 129: 10.PubMed
125.
Brummett BH, Boyle SH, Ortel TL, et al. Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Psychosom Med. 2010; 72: 333-339.PubMedCentralPubMed
126.
Stewart JC, Janicki-Deverts D, Muldoon MF, Kamarck TW. Depressive symptoms moderate the influence of hostility on serum interleukin-6 and C-reactive protein. Psychosom Med. 2008; 70: 197-204.PubMed
127.
Gandhi RT, Walker BD. Immunologic control of HIV-1. Annu Rev Med. 2002; 53: 149-172.PubMed
128.
Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol. 1989; 44: 153-205.PubMed
129.
Porter KM, Sutliff RL. HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med. 2012; 53: 143-159.PubMedCentralPubMed
130.
Maggi P, Maserati R, Antonelli G. Atherosclerosis in HIV patients: A new face for an old disease. Aids Rev. 2006; 8: 204-209.PubMed
131.
Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med Suppl. 2005; 118: 23-28.
132.
Hurwitz BE, Klimas NG, Llabre MM, et al. HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk. Cardiovasc Toxicol. 2004; 4: 303-315.PubMed
Metadata
Title
The ABCs of Trait Anger, Psychological Distress, and Disease Severity in HIV
Authors
Roger C. McIntosh, Ph.D.
Barry E. Hurwitz, Ph.D.
Michael Antoni, Ph.D.
Alex Gonzalez, B.A.
Julia Seay, M.S.
Neil Schneiderman, Ph.D.
Publication date
01-06-2015
Publisher
Springer US
Published in
Annals of Behavioral Medicine / Issue 3/2015
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-014-9667-y

Other articles of this Issue 3/2015

Annals of Behavioral Medicine 3/2015 Go to the issue

Invited Commentary

Mindfully Considering Treatment of Fibromyalgia: a Comment on Cash et al.

Letter to the Editor

Considering Cumulative Risk for Cardiovascular Disease in Relation to Cognitive Function: a Comment on DeRight et al.

Original Article

Individual and Household Predictors of Adolescents’ Adherence to a Web-Based Intervention

Original Article

Mindfulness Meditation Alleviates Fibromyalgia Symptoms in Women: Results of a Randomized Clinical Trial

Original Article

Do Assessments of HIV Risk Behaviors Change Behaviors and Prevention Intervention Efficacy? An Experimental Examination of the Influence of Type of Assessment and Risk Perceptions

Original Article

A Randomized Controlled Trial to Increase HIV Preventive Information, Motivation, and Behavioral Skills in Ugandan Adolescents